JPWO2020027575A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020027575A5
JPWO2020027575A5 JP2021505200A JP2021505200A JPWO2020027575A5 JP WO2020027575 A5 JPWO2020027575 A5 JP WO2020027575A5 JP 2021505200 A JP2021505200 A JP 2021505200A JP 2021505200 A JP2021505200 A JP 2021505200A JP WO2020027575 A5 JPWO2020027575 A5 JP WO2020027575A5
Authority
JP
Japan
Prior art keywords
substrate
cell
cell layer
temperature
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021505200A
Other languages
Japanese (ja)
Other versions
JP7228672B2 (en
JP2021531807A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2019/009544 external-priority patent/WO2020027575A1/en
Publication of JP2021531807A publication Critical patent/JP2021531807A/en
Publication of JPWO2020027575A5 publication Critical patent/JPWO2020027575A5/ja
Application granted granted Critical
Publication of JP7228672B2 publication Critical patent/JP7228672B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明の一実施形態は、(a)0℃~30℃のいずれかの地点の温度で溶解点を有するか、疎水性から親水性に変換される第1の基材上に第1の細胞層を形成する段階と、(b)酵素によって分解される第2の基材上に第2の細胞層を形成する段階と、(c)前記第1の細胞層と前記第2の細胞層を接触させる段階と、(d)前記第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度を提供し、前記第1の基材を選択的に除去する段階と、(e)酵素を含む溶液に前記第2の基材を接触させて前記第2の基材を選択的に除去する段階と、を含む、多層細胞シートの製造方法を提供する。 One embodiment of the present invention comprises: (a) a first cell on a first substrate that has a melting point or is converted from hydrophobic to hydrophilic at a temperature anywhere from 0°C to 30°C; (b) forming a second cell layer on a second substrate that is enzymatically degraded; (c) separating said first cell layer and said second cell layer; (d) providing a temperature below the melting point of the first substrate or a temperature at which the first substrate is converted to hydrophilic to selectively remove the first substrate; and (e) contacting the second substrate with a solution containing an enzyme to selectively remove the second substrate.

本発明の一実施形態は、(a)0℃~30℃のいずれかの地点の温度で溶解点を有するか、疎水性から親水性に変換される第1の基材上に第1の細胞層を形成する段階と、 One embodiment of the present invention comprises: (a) a first cell on a first substrate that has a melting point or is converted from hydrophobic to hydrophilic at a temperature anywhere from 0°C to 30°C; forming a layer;

(d)前記第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度を提供し、前記第1の基材を選択的に除去する段階と、 (d) selectively removing the first substrate by providing a temperature below the melting point of the first substrate or at which the first substrate is converted to hydrophilic;

本発明による多層細胞シートの製造方法は、簡単な方法で多層の細胞層が積層された細胞シートを製造できるという長所がある。前記多層細胞シートの製造方法は、0℃~30℃のいずれかの地点の温度で溶解点を有するか、疎水性から親水性に変換される第1の基材、及び酵素によって分解される第2の基材を使用して細胞層を積層した後、選択的にいずれかの基材を除去し得る。これを用いて選択的に除去された基材によって露出される細胞層上に追加の細胞層を積層し得る。また、除去されていない基材上に積層された細胞層が備えられているので、容易に転写し得、転写後、選択的に残りの基材を除去して多層細胞層の移植が可能である。 The method for producing a multilayered cell sheet according to the present invention has the advantage of being able to produce a cell sheet in which multiple cell layers are laminated by a simple method. The method for producing a multilayer cell sheet includes a first substrate that has a melting point at a temperature between 0° C. and 30° C. or that is converted from hydrophobic to hydrophilic, and a first substrate that is decomposed by an enzyme. After stacking cell layers using two substrates, either substrate can be selectively removed. This can be used to overlay additional cell layers on top of the cell layers exposed by the selectively removed substrate. In addition, since the cell layer is laminated on the non-removed base material, it can be easily transferred, and after the transfer, the remaining base material can be selectively removed to allow multi-layered cell layer transplantation. be.

本発明の一実施形態によれば、(d)段階及び(e)段階が順次行われ、(d)段階と(e)段階の間に、(d’)露出された前記第1の細胞層と追加の第1の基材上に備えられた追加の第1の細胞層を接触させた後、前記第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度を提供し、前記追加の第1の基材を選択的に除去する段階をさらに含んでもよい。具体的には、(c)段階により形成される「第1の基材/第1の細胞層/第2の細胞層/第2の基材」の積層構造体は、(d)段階及び(d’)段階によって「追加の第1の細胞層/第1の細胞層/第2の細胞層/第2の基材」の積層構造体が形成されてもよい。 According to one embodiment of the present invention, steps (d) and (e) are performed sequentially, and between steps (d) and (e), (d′) the exposed first cell layer and an additional first cell layer provided on an additional first substrate at a temperature below the melting point of the first substrate or the first substrate converts to hydrophilic and selectively removing said additional first substrate. Specifically, the laminated structure of "first base material/first cell layer/second cell layer/second base material" formed by the step (c) includes steps (d) and ( The step d′) may form a laminated structure of “additional first cell layer/first cell layer/second cell layer/second substrate”.

本発明の一実施形態によれば、(a)段階及び(c)段階は、35℃~40℃の雰囲気、具体的には、36℃~38℃の雰囲気、より具体的には、36℃~37℃の雰囲気で行われてもよい。これは、前記第1の基材は、0℃~30℃のいずれかの地点の温度で溶解点を有するか、疎水性から親水性に変換される性質を持つので、前記温度範囲(すなわち、35℃~40℃)の雰囲気で第1の基材が固相の形態または疎水性を保つようにし、細胞が活発に活動するようにして細胞層の形成を促進させるためである。同様に、(d’)段階の追加の第1の基材も第1の基材と同じ性質を持つので、追加の第1の細胞層の形成及び追加の第1の細胞層を積層する過程は、35℃~40℃の雰囲気で行われてもよい。さらに、(b)段階も細胞層の形成を促進させるため、35℃~40℃の雰囲気、具体的には、36℃~38℃の雰囲気、より具体的には、36℃~37℃の雰囲気で行われてもよい。 According to one embodiment of the present invention, steps (a) and (c) are carried out in an atmosphere of 35°C to 40°C, specifically 36°C to 38°C, more specifically 36°C. It may be performed in an atmosphere of ~37°C. This is because the first substrate has a melting point at a temperature of any point from 0° C. to 30° C. or has a property of being converted from hydrophobic to hydrophilic, so the temperature range (that is, This is because the first base material maintains a solid phase form or hydrophobicity in an atmosphere of 35° C. to 40° C., and the cells are actively activated to promote the formation of a cell layer. Similarly, since the additional first substrate in step (d') also has the same properties as the first substrate, the process of forming an additional first cell layer and stacking the additional first cell layer may be performed in an atmosphere of 35°C to 40°C. Furthermore, in step (b), an atmosphere of 35° C. to 40° C., specifically an atmosphere of 36° C. to 38° C., more specifically an atmosphere of 36° C. to 37° C. is used to promote the formation of the cell layer. may be performed in

本発明の一実施形態によれば、前記ポリホスファゼン系ハイドロゲルは、温度感応性のポリホスファゼン系化合物を含み、溶解点が約4℃~約10℃に調節されてもよい。例えば、大韓民国公開公報第10-2017-0061530号に開示された温度感応性及び架橋性ホスファゼン系ハイドロゲル、大韓民国公開公報第10-2014-0016521号に開示された分解速度の調節が可能なイオン基を有するホスファゼン系高分子、大韓民国公開公報第10-2007-0076386号に開示された生分解性温度感応性ポリホスファゼン系ハイドロゲルが、本発明のポリホスファゼン系ハイドロゲルに含まれてもよい。 According to one embodiment of the present invention, the polyphosphazene-based hydrogel may comprise a temperature-sensitive polyphosphazene-based compound and have a melting point adjusted to between about 4°C and about 10°C. For example, temperature-sensitive and crosslinkable phosphazene-based hydrogels disclosed in Korean Patent Publication No. 10-2017-0061530, ionic groups capable of controlling the decomposition rate disclosed in Korean Patent Publication No. 10-2014-0016521 may be included in the polyphosphazene-based hydrogel of the present invention, such as the biodegradable temperature-sensitive polyphosphazene-based hydrogel disclosed in Korean Patent Publication No. 10-2007-0076386.

本発明の一実施形態によれば、前記プルロニック系ハイドロゲルは、プルロニック高分子を用いて、溶解点の温度を約0℃~30℃に調節してもよい。前記プルロニック高分子は、ポリエチレンオキシド(PEO)-ポリプロピレンオキシド(PPO)-ポリエチレンオキシド(PEO)の構造(PEO-PPO-PEO)を有する高分子であればすべて使用可能である。例えば、Fで始まるF38、F68、、F77、F98、F108、F127誘導体などと、Lで始まるL31、L42、L43、L44、L62、L72、L101誘導体などと、Pで始まるP75、P103、P104誘導体など(すべて商品名)が含まれてもよい。より具体的には、前記プルロニック高分子のうち、米国食品医薬局(FDA)の許可を受けた分子量が約8,700ダルトンであるF68と分子量が約12,600ダルトンであるF127を使用してもよい。 According to one embodiment of the present invention, the Pluronic-based hydrogel may have a melting point temperature adjusted to about 0° C. to 30° C. using a Pluronic polymer. Any polymer having a polyethylene oxide (PEO)-polypropylene oxide (PPO)-polyethylene oxide (PEO) structure (PEO-PPO-PEO) may be used as the pluronic polymer. For example, F38, F68, F77, F98, F108, F127 derivatives starting with F, L31, L42, L43, L44, L62, L72, L101 derivatives starting with L, and P75, P103, P104 derivatives starting with P etc. (all product names) may be included. More specifically, F68 with a molecular weight of about 8,700 daltons and F127 with a molecular weight of about 12,600 daltons, which are approved by the US Food and Drug Administration (FDA), are used among the pluronic polymers. good too.

ただし、前記第1の基材は、ポリホスファゼン系ハイドロゲル、プルロニック系ハイドロゲルに限定されるものではなく、30℃以下の温度で溶解点を有するハイドロゲルであれば、前記第1の基材及び/又は追加の第1の基材として適用してもよい。 However, the first base material is not limited to polyphosphazene-based hydrogels and pluronic-based hydrogels, and any hydrogel having a melting point at a temperature of 30° C. or lower can be used as the first base material. and/or may be applied as an additional first substrate.

本発明の一実施形態によれば、(d)段階は、前記第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度を持つ溶液に前記第1の基材を接触させるか、または周辺温度を前記第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度に下げるものであってもよい。具体的には、(d)段階の第1の基材を選択的に除去する過程は、(c)段階により形成される「第1の基材/第1の細胞層/第2の細胞層/第2の基材」の積層構造体は、第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度を持つ溶液に浸漬して、第1の基材を選択的に除去するものであってもよい。また、(d)段階の第1の基材を選択的に除去する過程は、(c)段階により形成される「第1の基材/第1の細胞層/第2の細胞層/第2の基材」の積層構造体の周辺温度(大気温度)を第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度に下げて第1の基材を選択的に除去するものであってもよい。このとき、前記第1の基材の溶解点以下の温度を持つ溶液は、約4℃~約30℃の温度を持つ生理食塩水であってもよい。また、前記周辺温度(大気温度)は、約4℃~約30℃であってもよい。同様に、(d’)段階の追加の第1の基材を選択的に除去する過程は、約4℃~約30℃の温度を持つ生理食塩水に積層構造体を浸漬して選択的に追加の第1の基材を除去するか、周辺温度(大気温度)を第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度に下げるものであってもよい。前記第1の基材又は追加の第1の基材の溶解点以下の温度を持つ溶液、または周辺温度が20℃未満で積層構造物の細胞層が損傷する可能性がある場合、ポリ(N-イソプロピルアクリルアミド)基材またはポリ(N-イソプロピルアクリルアミド)で表面処理された基材を用いて、20℃~30℃で前記第1の基材を選択的に除去し得る。 According to one embodiment of the present invention, step (d) includes adding the first or lowering the ambient temperature to a temperature below the melting point of said first substrate or a temperature at which said first substrate is converted to hydrophilic. Specifically, the process of selectively removing the first base material in step (d) includes the "first base material/first cell layer/second cell layer" formed by step (c). The laminated structure of "/second substrate" is immersed in a solution having a temperature below the melting point of the first substrate or a temperature at which the first substrate is converted to hydrophilic, and the first substrate It may be one that selectively removes the substrate. In addition, the process of selectively removing the first base material in step (d) is performed by removing the "first base material/first cell layer/second cell layer/second cell layer" formed by step (c). The ambient temperature (ambient temperature) of the laminated structure of the "substrate" is lowered to a temperature below the melting point of the first substrate or to a temperature at which the first substrate is converted to hydrophilic, and the first substrate may be selectively removed. At this time, the solution having a temperature below the melting point of the first base material may be physiological saline having a temperature of about 4°C to about 30°C. Also, the ambient temperature (ambient temperature) may be from about 4°C to about 30°C. Similarly, the step of selectively removing the additional first substrate in step (d') comprises immersing the laminated structure in a saline solution having a temperature of about 4°C to about 30°C to selectively Removing the additional first substrate or lowering the ambient temperature (ambient temperature) to a temperature below the melting point of the first substrate or at which said first substrate is converted to hydrophilic. may If the solution has a temperature below the melting point of the first substrate or additional first substrate, or if the ambient temperature is less than 20° C. and the cell layer of the laminated structure may be damaged, poly(N -isopropylacrylamide) substrates or substrates surface treated with poly(N-isopropylacrylamide) can be used to selectively remove said first substrate at 20°C to 30°C.

Claims (10)

(a)0℃~30℃のいずれかの地点の温度で溶解点を有するか、疎水性から親水性に変換される第1の基材上に第1の細胞層を形成する段階と、
(b)酵素によって分解される第2の基材上に第2の細胞層を形成する段階と、
(c)前記第1の細胞層と前記第2の細胞層を接触させる段階と、
(d)前記第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度を提供し、前記第1の基材を選択的に除去する段階と、
(d’)露出した前記第1の細胞層と追加の第1の基材上に備えられた追加の第1の細胞層を接触させた後、前記追加の第1の基材の溶解点以下の温度または前記追加の第1の基材が親水性に変換される温度を提供し、前記追加の第1の基材を選択的に除去する段階と、
(e)酵素を含む溶液に前記第2の基材を接触させて前記第2の基材を選択的に除去する段階と、を含み、
(d)段階、(d’)段階及び(e)段階が順次行われ、
(d’)段階は、2回以上繰り返して行われ、前記第1の細胞層上に複数の追加の第1の細胞層を形成する、多層細胞シートの製造方法。
(a) forming a first cell layer on a first substrate that has a melting point or is converted from hydrophobic to hydrophilic at a temperature anywhere from 0° C. to 30° C.;
(b) forming a second cell layer on a second substrate that is enzymatically degraded;
(c) contacting the first cell layer and the second cell layer;
(d) selectively removing the first substrate by providing a temperature below the melting point of the first substrate or at which the first substrate is converted to hydrophilic;
(d′) after contacting the exposed first cell layer with an additional first cell layer provided on an additional first substrate, below the melting point of the additional first substrate or a temperature at which the additional first substrate is converted to hydrophilic and selectively removing the additional first substrate;
(e) selectively removing the second substrate by contacting the second substrate with a solution containing an enzyme ;
(d) step, (d') step and (e) step are performed sequentially,
(d') The method for producing a multilayered cell sheet, wherein step (d') is repeated twice or more to form a plurality of additional first cell layers on the first cell layer .
(d)段階は、前記第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度を持つ溶液に前記第1の基材を接触させるか、または周辺温度を前記第1の基材の溶解点以下の温度または前記第1の基材が親水性に変換される温度に下げることを特徴とする、請求項1に記載の多層細胞シートの製造方法。 The step (d) includes contacting the first substrate with a solution having a temperature below the melting point of the first substrate or a temperature at which the first substrate is converted to hydrophilicity, or 2. The method for producing a multilayer cell sheet according to claim 1, wherein the temperature is lowered to a temperature below the melting point of the first substrate or a temperature at which the first substrate is converted to hydrophilicity. 前記第1の細胞層及び前記第2の細胞層は、それぞれ前記第1の基材及び前記第2の基材上に培養されて形成されることを特徴とする、請求項1に記載の多層細胞シートの製造方法。 The multilayer according to claim 1, wherein the first cell layer and the second cell layer are formed by culturing on the first substrate and the second substrate, respectively. A method for producing a cell sheet. (a)段階及び(c)段階は、35℃~40℃の雰囲気で行われることを特徴とする、 請求項1に記載の多層細胞シートの製造方法。 The method for producing a multilayer cell sheet according to claim 1, wherein steps (a) and (c) are performed in an atmosphere of 35°C to 40°C. 前記第1の基材は、ポリホスファゼン系ハイドロゲル、プルロニック系ハイドロゲル及びポリ(N-イソプロピルアクリルアミド)のうち少なくとも1種を含み、
前記プルロニック系ハイドロゲルは、ポリエチレンオキシド(PEO)-ポリプロピレンオキシド(PPO)-ポリエチレンオキシド(PEO)の構造(PEO-PPO-PEO)を有する高分子を利用する材料である、請求項1に記載の多層細胞シートの製造方法。
The first base material comprises at least one of polyphosphazene-based hydrogel, pluronic-based hydrogel and poly(N-isopropylacrylamide) ,
The pluronic hydrogel according to claim 1, which is a material that utilizes a polymer having a polyethylene oxide (PEO)-polypropylene oxide (PPO)-polyethylene oxide (PEO) structure (PEO-PPO-PEO) . A method for producing a multilayer cell sheet.
前記第1の基材は、ポリ(N-イソプロピルアクリルアミド)で表面処理されたことを特徴とする、請求項1に記載の多層細胞シートの製造方法。 2. The method for producing a multilayer cell sheet according to claim 1, wherein the first base material is surface-treated with poly(N-isopropylacrylamide). 前記第2の基材は、カルボキシメチルセルロースまたはアルジネートを含むハイドロゲル基材であることを特徴とする、請求項1に記載の多層細胞シートの製造方法。 2. The method for producing a multilayer cell sheet according to claim 1, wherein the second base material is a hydrogel base material containing carboxymethylcellulose or alginate. 前記カルボキシメチルセルロースまたはアルジネートは、チラミンでコンジュゲーションされたことを特徴とする、請求項に記載の多層細胞シートの製造方法。 [8] The method of claim 7 , wherein the carboxymethylcellulose or alginate is conjugated with tyramine. 前記酵素は、カルボキシメチルセルロース分解酵素またはアルジネート分解酵素であることを特徴とする、請求項1に記載の多層細胞シートの製造方法。 2. The method for producing a multilayer cell sheet according to claim 1, wherein the enzyme is carboxymethylcellulose-degrading enzyme or alginate-degrading enzyme. 前記第1の細胞層及び前記第2の細胞層は、それぞれ間葉系幹細胞(MSCs;mesenchymal stem cells)、筋組織前駆細胞(myocyte precursor cells)、筋細胞(myocytes)、繊維芽細胞(fibroblasts)、軟骨細胞(chondrocytes)、内皮細胞(endothelial cells)、上皮細胞(epithelial cells)、胚性幹細胞(ESCs;embryonic stem cells)、造血幹細胞(hematopoietic stem cells)、付着依存性細胞前駆体(anchorage-dependent cell precursors)、誘導された全分化能幹細胞(iPSCs;induced pluripotent stem cells)、及び心筋細胞(cardiomyocytes)からなる群から選ばれる細胞を含むことを特徴とする、請求項1に記載の多層細胞シートの製造方法。 The first cell layer and the second cell layer contain mesenchymal stem cells (MSCs), myocyte precursor cells, myocytes, and fibroblasts, respectively. , chondrocytes, endothelial cells, epithelial cells, embryonic stem cells (ESCs), hematopoietic stem cells, anchorage-dependent cell precursors 2. The multilayered cell sheet according to claim 1, comprising cells selected from the group consisting of cell precursors, induced pluripotent stem cells (iPSCs), and cardiomyocytes. manufacturing method.
JP2021505200A 2018-07-31 2019-07-31 Multilayer cell sheet manufacturing method and multilayer cell sheet manufactured using the same Active JP7228672B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180089461 2018-07-31
KR10-2018-0089461 2018-07-31
PCT/KR2019/009544 WO2020027575A1 (en) 2018-07-31 2019-07-31 Method for manufacturing multilayered cell sheet, and multilayered cell sheet manufactured using same

Publications (3)

Publication Number Publication Date
JP2021531807A JP2021531807A (en) 2021-11-25
JPWO2020027575A5 true JPWO2020027575A5 (en) 2022-09-12
JP7228672B2 JP7228672B2 (en) 2023-02-24

Family

ID=69232615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505200A Active JP7228672B2 (en) 2018-07-31 2019-07-31 Multilayer cell sheet manufacturing method and multilayer cell sheet manufactured using the same

Country Status (6)

Country Link
US (1) US20220080083A1 (en)
EP (1) EP3831419A4 (en)
JP (1) JP7228672B2 (en)
KR (1) KR102273719B1 (en)
CN (1) CN112512601A (en)
WO (1) WO2020027575A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220083621A (en) * 2020-12-11 2022-06-20 주식회사 로킷헬스케어 Composition for Tissue Regeneration And Method for Preparing the Same
KR102644326B1 (en) 2021-03-26 2024-03-11 단국대학교 천안캠퍼스 산학협력단 Fibrinogen-based cell sheet, and method for preparing thereof
KR102644327B1 (en) 2021-03-26 2024-03-11 단국대학교 천안캠퍼스 산학협력단 Fibrinogen-based 3dimensional spheroid cell sheet, and method for preparing thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2264147A1 (en) * 2000-07-21 2010-12-22 Cellseed Inc. Epidermal cultured cell sheet, multi-layered cultured skin sheet and processes for producing those sheets
JP3935093B2 (en) 2003-02-06 2007-06-20 株式会社セルシード Highly engrafted regenerative corneal epithelial cell sheet, production method and use thereof
WO2004101774A1 (en) * 2003-05-14 2004-11-25 Japan Tissue Engineering Co. Ltd Cell culture method and cultured tissue
JP5349728B2 (en) * 2003-10-09 2013-11-20 一般財団法人川村理化学研究所 Cell culture substrate and cell culture method
ES2693609T3 (en) * 2005-02-28 2018-12-12 Cellseed Inc. Sheet of cultured cells, method for their production and method for their application
KR100784485B1 (en) 2006-01-18 2007-12-11 한국과학기술연구원 Biodegradable and thermosensitive polyorganophosphazene hydrogel, preparation method thereof and use thereof
KR101480363B1 (en) 2012-07-30 2015-01-09 한국과학기술연구원 Poly(organophosphazene) containing degradation-controllable ionic group, preparation method thereof and use thereof
KR102254082B1 (en) 2012-08-24 2021-05-18 고쿠리쓰 겐큐 가이하쓰 호징 리가가쿠 겐큐소 Method for producing retinal pigment epithelial cell sheet
WO2014148321A1 (en) 2013-03-19 2014-09-25 学校法人東京女子医科大学 Cell sheet laminate containing myoblasts and method for producing same
US10526582B2 (en) * 2013-05-16 2020-01-07 Trustees Of Boston University Multi-layered cell constructs and methods of use and production using enzymatically degradable natural polymers
US10159766B2 (en) * 2013-05-31 2018-12-25 Iheart Japan Corporation Layered cell sheet incorporating hydrogel
US20180171299A1 (en) * 2015-06-05 2018-06-21 National Cancer Center Functional cell sheet using electrically activated conductive polymer, and method of producing same
WO2017023955A1 (en) * 2015-08-02 2017-02-09 Steven Yu Bioengineered corneal tissue
JP2017077985A (en) * 2015-10-20 2017-04-27 旭硝子株式会社 Bilayer glass structure for refrigeration show case and refrigeration show case
JP6923204B2 (en) 2015-11-05 2021-08-18 学校法人東京女子医科大学 A method for producing a laminated cell sheet composition, a laminated cell sheet composition produced thereby, and an apparatus for producing the same.
KR101759218B1 (en) 2015-11-26 2017-07-31 한국과학기술연구원 Thermosensitive and chemically cross-linkable phosphazene hydrogels, preparation method thereof and use thereof
US10646372B2 (en) 2015-12-03 2020-05-12 Avedro, Inc. Systems and methods for treating an eye with a mask device

Similar Documents

Publication Publication Date Title
US20180043656A1 (en) Oriented Multilayer Porous Film
Lee et al. Graphene: an emerging material for biological tissue engineering
Lee et al. Graphene oxide-decorated PLGA/collagen hybrid fiber sheets for application to tissue engineering scaffolds
JP7228672B2 (en) Multilayer cell sheet manufacturing method and multilayer cell sheet manufactured using the same
Wang et al. Using a mild hydrogelation process to confer stable hybrid hydrogels for enzyme immobilization
JPWO2020027575A5 (en)
US20160151747A1 (en) Porous Nanomembranes
JP2011514147A5 (en)
US9492952B2 (en) Super-hydrophilic structures
Ma et al. Selective adhesion and controlled activity of yeast cells on honeycomb-patterned polymer films via a microemulsion approach
CN106902393B (en) Preparation method of mesoporous bioactive glass nanotube bracket
Wang et al. Laser-induced graphene papers with tunable microstructures as antibacterial agents
US8293046B2 (en) Process for production of porous body and uses thereof
Cho et al. Pore size effect on the formation of polymer nanotubular structures within nanoporous templates
US8277829B2 (en) Nano/macroporous bone tissue scaffolds for regenerative medicine
US20190390162A1 (en) Methods of Manufacturing and Assembling Cell-Containing Blocks
KR102139544B1 (en) A process for producing a polyimide foam and a polyimide foam produced thereby
KR101772861B1 (en) Polymer regeneration membrane, and method for preparing thereof
CN100503693C (en) 3-D porous frame material of poly-lactic acid-polyether block copolymer and its preparation method
KR101960334B1 (en) Method for manufacturing blockcopolymer multi-layered thin film and the blockcopolymer multi-layered thin film manufacturing by the method
Pan et al. Surface-segregation-induced nanopapillae on FDTS-blended PDMS film and implications in wettability, adhesion, and friction behaviors
Ahadian et al. The emerging applications of graphene oxide and graphene in tissue engineering
WO2017180991A1 (en) Graft scaffold with plasmonic activity, and methods of making and using same
Velayudhan et al. Fabrication of Honeycomb Patterned Polyurethane Membranes for Biomedical Applications
JP5926696B2 (en) Method for producing porous film